- Revolutionising cancer treatment, using complex data integration
- Accelerating cure through innovation and precision medicine
- Excelling by combining global partnerships with Cambridge
Dr Shubha Anand and Dr Ezequiel Martin Rodriguez highlight the work of the Cancer Molecular Diagnostics Laboratory (CMDL). CMDL supports all of the MFICM clinical trials and studies.
Duncan Jodrell discusses the MFICM supported ATRiUM clinical trial for pancreatic cancer.
James Brenton, Mireia Crispin-Ortuzar and Ramona Woitek discuss MFICM supported research: integrated radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.
Cambridge Judge Business School was lit up for World Cancer Day.
MFICM co-authored article in British Journal of Cancer, 28 Jan 2021
Grant Stewart and Evis Sala discuss the MFICM supported WIRE clinical trial for renal cancer.
The recent publication: Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer is highlighted in the podcast.
Zohreh Shams, Helena Andres Terre and Nikola Simidjievski present their research on an AI based framework for Integrated Cancer Medicine.
